secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paysign, Inc. (PAYS)
CIK:        0001496443
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001683168-24-001715
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paysign FY2023 revenue up 24% to $47.3M; net income $6.5M; guides FY2024 revenue $54.5-56.7M
--------------------------------------------------------------------------------

- Full-year 2023 total revenue $47.3M (+24% YoY); net income $6.5M ($0.12 diluted EPS) vs $1.0M ($0.02) in 2022.
- Adjusted EBITDA $6.7M (+21% YoY); Q4 2023 revenue $13.7M (+29% YoY), net income $5.6M ($0.10 diluted EPS).
- Plasma centers up 20 net to 464; pharma patient affordability programs up 24 net to 43; revenue from pharma patient affordability +172% YoY.
- Exited FY2023 with $17.0M unrestricted cash, zero debt; repurchased 394,558 shares for $1.1M.
- FY2024 guidance: revenue $54.5-56.7M, net income $2-3M ($0.04-0.06 diluted EPS), adjusted EBITDA $8-9M ($0.15-0.17 diluted EPS).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496443/000168316824001715/0001683168-24-001715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496443/000168316824001715/paysign_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer